Armando Marull, member of the Quality Assurance Team of the RIPL_Effect research team, delivered a presentation of a very interesting topic: inducing regulatory T cells to suppress the physiological mechanisms that participate in the health outcomes of autoimmune encephalomyelitis. The article Armando presented was published by Zohar, Y. et al. in 2014 in the Journal of Clinical Investigation (click here to access the article). Among the authors’ findings were that administration of anti-CXCL11 antibodies prevented remission and relapse of autoimmune encephalomyelitis. This reduced remission and relapse resulted from reduced concentration of CD4+ T cells at the autoimmune site.